.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Clinical Decision Making in Advanced NSCLC without Actionable Mutations

EP. 1: Dr. Brahmer on Treatment Following Progression on First-line Immunotherapy in NSCLC

March 8th 2023

Julie Renee Brahmer, MD, discusses clinical trials investigating treatment options for patients with non–small cell lung cancer following progression after first-line immunotherapy.

EP. 2: Dr. Santos on the Current Treatment Landscape in Squamous Cell Carcinoma of the Lung

March 15th 2023

Edgardo S. Santos, MD, FACP, discusses the current treatment landscape for patients with squamous cell carcinoma of the lung.

EP. 3: Clinical Decision Making in Advanced NSCLC without Actionable Mutations

April 21st 2023